Clinical Trial Update: Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of combining empagliflozin with metformin for 24 weeks in treatment-naive adults with Type 2 diabetes; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)
• metformin (metformin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2, Hyperglycemia | Phase 3 | Status: COMPLETED | Results posted: 2016-02-19